Premium
Early-stage investment firm Ventureast is expecting the year to be eventful. The firm is aiming to exit a couple of its older investments, hit a final close of a technology-focussed fund and launch its next life sciences fund in 2018. The two-decade-old firm, which has about $325 million under management ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
